FOCAL CEREBRAL ISCHEMIA--PATHOPHYSIOLOGY, ACUTE THERAPY, RECOVERY OF FUNCTION
FOCAL CEREBRAL ISCHEMIA--PATHOPHYSIOLOGY, ACUTE THERAPY, RECOVERY OF FUNCTION
批准号:
6111981
负责人:
MYRON DAVID GINSBERG
金额:
$15.29万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-01 至 2000-05-31
关键词:
amphetamines apoptosis autoradiography bioenergetics brain disorder chemotherapy brain metabolism cerebral ischemia /hypoxia cerebrovascular occlusions electrophysiology free radical oxygen gene expression glutamates hemodynamics histopathology in situ hybridization induced hypothermia laboratory rat neural plasticity neuropharmacology neuroprotectants neuropsychological tests neurotrophic factors reperfusion
中文摘要
局灶性脑梗死后最初几小时内的生化和离子事件
血管闭塞决定了细胞的范围和强度
死亡,并可能提供关键的刺激,以随后的功能
大脑的重组和恢复。该项目采用了
广泛表征的微创光血栓模型
大脑中动脉(MCA)闭塞-一种与人类相关的模型
血栓栓塞性中风一个主要目的是表征因素
负责产生急性生物能应激的缺血
半暗带,包括过度局部代谢/血流解耦,
反复出现缺血性去极化这些过程之间的关系
谷氨酸和其他神经递质的局部释放,
氧自由基的本地生产,将被探索。分析
局部细胞骨架蛋白水解和光镜和电镜
组织病理学将提供结构相关性。调节急性
半影区的代谢事件将通过诱导额外的
去极化,轻度高温或低温,早期部分
再灌注,以及影响谷氨酸系统的药物。第二
主要目的是确定这些急性事件如何影响随后的
功能恢复模式,通过神经行为评估
电池,通过受影响前肢区域的葡萄糖代谢活化,以及
通过表达神经营养因子生长的信使RNA和蛋白质
因子及其TRK受体。我们将辨别是否急性
保护性策略可能有助于或矛盾地阻碍后来的功能性
重组,我们将评估的机制,
安非他明结合症状-
相关经验。该项目广泛使用了三种新的-
三维放射自显影图像平均策略结合
用神经行为学、原位杂交、免疫组织化学和
形态学方法
英文摘要
Biochemical and ionic events within the first few hours after focal
vascular occlusion critically determine the extent and intensity of cell
death and may provide critical stimuli to subsequent functional
rearrangement and recovery of the brain. This project employs an
extensively characterized, minimally invasive model of photothrombotic
middle cerebral artery (MCA) occlusion -a model relevant to human
thromboembolic stroke. A major aim is to characterize factors
responsible for engendering acute bioenergetic stress in the ischemic
penumbra, including excessive local metabolism/blood flow uncoupling and
repeated ischemic depolarizations. The relationship of these processes
to the local release of glutamate and other neurotransmitters, and to
the local production of oxygen radicals, will be explored. Analysis of
local cytoskeletal proteolysis and light- and electron microscopic
histopathology will provide structural correlates. Modulation of acute
metabolic events in the penumbra will be achieved by inducing additional
depolarizations, by mild hyperthermia or hypothermia, by early partial
reperfusion, and by agents affecting the glutamate system. The second
major aim is to determine how these acute events influence subsequent
patterns of functional recovery, as assessed by a neurobehavioral
battery, by glucose-metabolic activation of affected forelimb areas, and
by the expression of messenger RNA and protein for neurotrophin growth
factors and their trk receptors. We shall discern whether acute
protective strategies might aid or paradoxically hinder later functional
reorganization, and we shall assess the mechanisms underlying the
enhancement of functional recovery by amphetamine coupled with symptom-
relevant experience. The project makes extensive use of novel three-
dimensional autoradiographic image-averaging strategies in conjunction
with neurobehavior, in situ hybridization, immunohistochemistry and
morphologic methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALIAS II/III Trial:Albumin Therapy in Ischemic Stroke
-
批准号:6796049
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2004
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
SHARED CONFOCAL MICROSCOPY FACILITY
-
批准号:6577453
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:7064212
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6669554
-
项目类别:
-
资助金额:$57.35万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6744834
-
项目类别:
-
资助金额:$56.85万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
Azulenyl nitrones: neuroprotectants in stroke and trauma
-
批准号:6877742
-
项目类别:
-
资助金额:$58.54万
-
财政年份:2003
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY OF ACUTE ISCHEMIC STROKE
-
批准号:6326306
-
项目类别:
-
资助金额:$51.2万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY-TREATMENT OF ACUTE ISCHEMIC STROKE
-
批准号:6650873
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
-
批准号:6455813
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY OF ACUTE ISCHEMIC STROKE
-
批准号:6579862
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
HUMAN ALBUMIN THERAPY-TREATMENT OF ACUTE ISCHEMIC STROKE
-
批准号:6529473
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2001
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase IIi Multicenter Clincal Trial -- Albumin in Acute Ischemic Stroke
-
批准号:8105711
-
项目类别:
-
资助金额:$461.7万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7261865
-
项目类别:
-
资助金额:$590.92万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:6969095
-
项目类别:
-
资助金额:$285.57万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7498524
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ALIAS Phase lll Trial Albumin in Acute Ischemic Stroke
-
批准号:7623196
-
项目类别:
-
资助金额:$318.88万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
-
批准号:6320870
-
项目类别:
-
资助金额:$20.74万
-
财政年份:2000
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
CORE--SCIENTIFIC
-
批准号:6111984
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
ACUTE/SUBACUTE METABOLIC & HEMODYNAMIC TRAUMATIC BRAIN INJURY DETERMINANTS
-
批准号:6205036
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
CORE--COMPUTING AND IMAGE-PROCESSING
-
批准号:6111985
-
项目类别:
-
资助金额:$15.29万
-
财政年份:1999
-
负责人:MYRON DAVID GINSBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: